
|Articles|September 1, 2002
Cosmeceuticals are basically 'hope in a jar'
New Orleans - Before solid research establishes their validity, "cosmeceuticals" should be considered "hope in a jar," according to Leslie Baumann, M.D. In discussing the burgeoning field, where cosmetic products are reputed to have biologic effects, Dr. Baumann separated myth from fact at the American Academy of Dermatology annual meeting.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
AbbVie Files for Vitiligo Indication, Putting Systemic Therapy Under Regulatory Review
2
Icotrokinra Shows Superior Efficacy Over Advanced Oral Therapies in New Psoriasis Meta-Analysis
3
Nutrafol Expands Portfolio with First and Only Hair Loss Supplement for Male Patients 50 and Older
4
Introducing Dermatology Times NP/PA Connect
5











